Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Loses Trademark Suit Against Tianjin Zhongxin Pharmaceutical Group

This article was originally published in PharmAsia News

Executive Summary

Beijing Municipal Higher People's Court has rejected Merck's appeal to the Trademark Appeal Board under the State Administration for Industry and Commerce. It ruled that the registration of Tianjin Zhongxin Pharmaceutical Group's trademark logo should be approved. In 1998, Tianjin Zhongxin applied for its trademark logo registration, which Merck objected, claiming that the image was similar to its registered trademark in China and requested protection of the well-known logo. Insiders point out that the case reflects a major issue: the exhaustive policy of IP rights whereby ownership is secured only after completing all procedures, including trademark registration, administrative review and appeal of administrative proceeding. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts